Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07619443 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Clinical Study of MK-7262 and Enlicitide in Healthy Participants (MK-7262-003)

StatusCompleted
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Lead sponsor: Merck Sharp & Dohme LLC to Merck Sharp & Dohme LLC Trial completed · Study completion date changed from estimate of Sep 12, 2026 to Sep 22, 2026 · Secondary endpoints: details revised at 8 of 14 entries · 1 more Show 4 more changesShow less
    • Trial completed
    • Study completion date changed from estimate of Sep 12, 2026 to Sep 22, 2026
    • Secondary endpoints: details revised at 8 of 14 entries
    • Eligibility criteria expanded, about 4 words
  2. Enrollment closed, study ongoing Site details revisedv4 Show 1 more changeShow less
    • Site details revised
  3. Start date changed from estimate of Jul 6, 2026 to Jul 1, 2026v3
  4. Recruitment opened Study sites: 0 to 1v2 Show 1 more changeShow less
    • Study sites: 0 to 1
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Merck (MSD)
407 trials monitored
See 29 trials at risk
The goal of this study is to learn what happens to a single dose of enlicitide over time in a healthy participant's body when the participant is given a single dose of MK-7262 and what happens to a single dose of MK-7262 over time in a healthy participant's body when the participant is given a single dose of enlicitide.
Trial Details
NCT Number NCT07619443
Lead Sponsor Merck Sharp & Dohme LLC
Conditions Healthy
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov